Bioactivity | Squalene synthase-IN-1 (compound 1) is a potent antihyperlipidemic agent acting through Squalene Synthase inhibition. Squalene synthase-IN-1 exhibits an outstanding antioxidant and anti-inflammatory activity. Squalene synthase-IN-1 displays a significant reduction not only of glucose but also of oxidative stress levels, while it did not cause any toxicity[1]. |
In Vivo | Squalene synthase-IN-1 (compound 1) (56 μmols/kg, 腹腔注射,每日2次) 具有抗高胆固醇/抗高血脂作用,可降低 TC 和 LDL 水平,并提高 HDL 水平[1]。 Animal Model: |
Name | Squalene synthase-IN-1 |
Formula | C17H19BrN2O2S |
Molar Mass | 395.31 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Matralis AN, et al. Effect of a new squalene synthase inhibitor on an ApoE-/- mouse model of atherosclerosis. Bioorg Med Chem. 2023 Jul 15;90:117378. |